Get the Weekly Intelligence Brief — top committee picks every Sunday.

INVX vs NOV

Innovex International, Inc. vs NOV Inc. — AI-powered side-by-side comparison
INVX
Innovex International, Inc.
61
Buy
VS
NOV
NOV Inc.
71
Buy
MetricINVXNOV
AI Score 61 71
Price $30.06 $21.02
P/E Ratio 33.87× 80.85×
ROE 7.9% 2.3%
Revenue Growth YoY
Gross Margin 27.7% 20.5%
Debt / Equity 0.07× 0.37×
Dividend Yield 0.0% 2.0%
RSI (14) 61.3 66.0
Beta 0.835 0.936
Expected Upside +0.7%

AI Committee View

Current Innellis committee reasoning for INVX versus NOV.
NOV leads by 10 points.

NOV scores 71/100 (Buy) versus INVX at 61/100 (Buy).

INVX Committee View
67% agreement
6 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is eps declining -67.8% yoy despite any revenue growth. The committee is constructive but not yet at full conviction.

Bull Case
  • Price-to-book of 1.4x is a discount to asset value — Value
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 32.6 is moderate-to-rich — Value
  • EPS declining -67.8% YoY despite any revenue growth — Growth
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
NOV Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is news sentiment is negative (-0.20 across 27 articles, 14d). The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • News sentiment is negative (-0.20 across 27 articles, 14d) — News
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
INVX Full Analysis NOV Full Analysis